Efficient large-scale screening of viral pathogens by fragment length identification of pooled nucleic acid samples (FLIPNAS)

The necessity for the large-scale screening of viral pathogens has been amply demonstrated during the COVID-19 pandemic. During this time, SARS-CoV-2 nucleic acid pooled testing, such as Dorfman-based group testing, was widely adopted in response to the sudden increased demand for detection. However, the current approach still necessitates the individual retesting of positive pools. Here, we established an efficient method termed the fragment-length identification of pooled nucleic acid samples (FLIPNAS), where all subsamples (n = 8) can be uniquely labelled and tested in a single-time detection among pools of samples. We used a novel and simple design of unique primers (UPs) to generate amplicons of unique lengths after reverse transcription and polymerase chain reaction to reach this aim. As a result, the unique lengths of the amplicons can be recognized and traced back to the corresponding UPs and specific samples. Our results demonstrated that FLIPNAS could recognize one to eight positive subsamples in a single test without retesting positive pools. The system also showed sufficient sensitivity for the mass monitoring of SARS-CoV-2 and no cross-reactivity against three common respiratory diseases. Moreover, the FLIPNAS results of 40 samples with a positive ratio of 7.8% were in 100% agreement with their individual detection results using the gold standard. Collectively, this study shows that the efficiency of nucleic acid pooling detection can be further improved by FLIPNAS, which can speed up testing and mitigate the urgent demand for resources.

Automated summary

The study introduces FLIPNAS, an efficient method for nucleic acid pooling detection, which can uniquely label and test all subsamples in a single-time detection among pools of samples. FLIPNAS can recognize one to eight positive subsamples without retesting positive pools, and it shows sufficient sensitivity for mass monitoring of SARS-CoV-2 without cross-reactivity against other respiratory diseases. This method can improve the efficiency of nucleic acid pooling detection, accelerate testing, and alleviate the urgent demand for resources.